SS
GYRE icon

SBI Securities’s Gyre Therapeutics GYRE Stock Holding History

SBI Securities’s Portfolio GYRE Stock Details GYRE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.19M Buy
170,837
+7,922
+5% +$61.5K 0.03% 245
2025
Q4 		$1.15M Sell
162,915
-4,951
-3% -$38.2K 0.03% 257
2025
Q3 		$1.25M Sell
167,866
-64,433
-28% -$489K 0.03% 246
2025
Q2 		$1.71M Buy
232,299
+108,670
+88% +$948K 0.05% 198
2025
Q1 		$954K Buy
123,629
+22,390
+22% +$246K 0.03% 254
2024
Q4 		$1.22M Buy
+101,239
New +$1.3M 0.04% 227

Other funds holding GYRE

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return